🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vesalius Longevity Labs Inc. (CSE:VLAB)
Canada flag Canada · Delayed Price · Currency is CAD
1.680
+0.060 (3.70%)
At close: Nov 20, 2026

Vesalius Longevity Labs Company Description

Vesalius Longevity Labs Inc., together with its subsidiary, provides peptide-based therapeutics and wellness solutions in Europe, Middle East, North America, and internationally.

It develops and provides peptide-based therapies to support physiological functions, including metabolism, cognition, immune response, hormone regulation, and healthy aging.

The company also focuses on proactive, personalized care within the regenerative medicine and wellness sectors to address demands for therapies that promote long-term wellness and disease prevention.

Its products include injectable peptides; transdermal peptide patches; nasal and oral peptides; hydrogel technology; bioregulators; and topical peptide formulations.

The company serves healthcare providers, pharmaceutical companies, wellness clinics, and global distributors.

Vesalius Longevity Labs Inc. is based in Vancouver, Canada.

Vesalius Longevity Labs Inc.
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
CEOPradeep Albert

Contact Details

Address:
1055 West Georgia Street
Vancouver, BC V6E 4N7
Canada
Phone604 307 8290
Websitevesaliuslabs.com

Stock Details

Ticker SymbolVLAB
ExchangeCanadian Securities Exchange
Reporting CurrencyCAD
ISIN NumberCA92490K1093
SIC Code2834

Key Executives

NamePosition
Pradeep AlbertChief Executive Officer
Christopher CooperChief Financial Officer
Timmi StumpChief Operating Officer